A study by Montana-Loza et al. [22], including 170 patients with AIH-type 1, revealed that anti-Ro-52 was present in 38.2% of patients, while anti-SLA was positive in only 15.8% in whom 15.2% of them had concomitant positivity for both antibodies. This evidence concerns the gene TRIM21 and autoimmune hepatitis.